咪唑甲酰胺（NCS45388）的1-2期联合研究 - Suppr

Combination phase 1-II study of imidazole carboxamide (NCS45388).

作者信息

Wagner D E, Ramirez G, Weiss A J, Hill G

出版信息

Oncology. 1972;26(2):310-6. doi: 10.1159/000224680.

DOI:10.1159/000224680

PMID:5049924

Abstract

摘要

相似文献

Combination phase 1-II study of imidazole carboxamide (NCS45388).

Oncology. 1972;26(2):310-6. doi: 10.1159/000224680.

Mitomycin (Mutamycin).

Med Lett Drugs Ther. 1975 Jul 18;17(15):62-3.

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.

Cancer Chemother Rep. 1971 Jun;55(3):281-3.

Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.

Cancer Res. 1969 Nov;29(11):1944-51.

Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.

Cancer. 1972 Sep;30(3):654-9. doi: 10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x.

Chemotherapy in prevention of the recurrence of resectable cancer.

Annu Rev Med. 1978;29:149-75. doi: 10.1146/annurev.me.29.020178.001053.

The systemic chemotherapy of hepatic metastases.

Semin Oncol. 1983 Jun;10(2):148-58.

Clinical cancer chemotherapy aimed at potential cell regulators.

Arch Surg. 1970 Feb;100(2):167-72. doi: 10.1001/archsurg.1970.01340200055013.

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).

Cancer Chemother Rep. 1970 Apr;54(2):119-24.

[SM-108].

Gan No Rinsho. 1985 May;31(6 Suppl):757-66.

引用本文的文献

Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma.

Mar Drugs. 2022 Apr 28;20(5):301. doi: 10.3390/md20050301.

WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018 Feb 7;2(2):CD001215. doi: 10.1002/14651858.CD001215.pub2.

Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.

Med Oncol. 1995 Mar;12(1):35-40. doi: 10.1007/BF01571406.

Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.

J Cancer Res Clin Oncol. 1980;97(3):301-6. doi: 10.1007/BF00405782.

Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).

Ann Surg. 1974 Aug;180(2):167-74. doi: 10.1097/00000658-197408000-00007.

N-methyl antitumour agents. A distinct class of anticancer drugs?

Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.

Clinical pharmacokinetics of high-dose DTIC.

Cancer Chemother Pharmacol. 1991;28(6):475-9. doi: 10.1007/BF00685826.

Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study.

Invest New Drugs. 1991 Feb;9(1):105-8. doi: 10.1007/BF00194559.

Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.

Br J Cancer. 1976 Aug;34(2):174-9. doi: 10.1038/bjc.1976.140.

Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.

J Cancer Res Clin Oncol. 1979;95(3):281-6. doi: 10.1007/BF00410649.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Combination phase 1-II study of imidazole carboxamide (NCS45388).

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献